Tinea Versicolor Treatment Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Nizoral is the best-performing tinea versicolor treatment brand in July 2026, moving 100,000 units across 1 ASIN for 48.5% of Top 10 volume. Globe Pharmacy follows with 40,000 units (19.4%), ahead of Lamisil on 17,000 units (8.3%).

With 8 brands splitting the Top 10 and 76.2% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $4.85 to $16.88, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. On the growth side, B00JJIJVD6 leads positive momentum with ▲ 300.0% MoM growth on 800 units, with B0D9HY9NCF close behind at ▲ 133.3% MoM on 700 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.